首页> 外文期刊>Molecular Carcinogenesis >Hypoxia negatively regulates heparan sulfatase 2 expression in renal cancer cell lines
【24h】

Hypoxia negatively regulates heparan sulfatase 2 expression in renal cancer cell lines

机译:低氧负调节肝癌细胞硫酸乙酰肝素酶2表达

获取原文
获取原文并翻译 | 示例
           

摘要

Inactivation of von Hippel-Lindau (VHL), a tumor suppressor gene is often associated with clear cell renal cell carcinoma (ccRCC). VHL inactivation leads to multitude of responses including enhanced growth factor signaling such as bFGF2, SDF-1α, and HGF. Here, we have identified a novel VHL-inducible gene, heparan sulfatase 2 (HSulf-2) that attenuates heparan-binding growth factor such as bFGF2 signaling. VHL-mediated HIF-1 alpha degradation was essential to restore HSulf-2 expression. Mechanistically, HSulf-2 negatively regulated vimentin expression and knockdown of vimentin abolished cell migration. This study reveals a novel layer of regulation of heparan-binding growth factor signaling via modulation of heparan sulfate by HSulf-2 in ccRCC.
机译:抑癌基因von Hippel-Lindau(VHL)的失活通常与透明细胞肾细胞癌(ccRCC)相关。 VHL失活导致多种反应,包括增强的生长因子信号传导,例如bFGF2,SDF-1α和HGF。在这里,我们已经确定了一种新型的VHL诱导型基因,乙酰肝素硫酸酯酶2(HSulf-2),可减弱乙酰肝素结合生长因子,例如bFGF2信号传导。 VHL介导的HIF-1α降解对于恢复HSulf-2表达至关重要。机械上,HSulf-2负调节波形蛋白的表达和波形蛋白的敲低废除细胞迁移。这项研究揭示了在ccRCC中通过HSulf-2调节硫酸乙酰肝素来调节肝素结合生长因子信号传导的新层。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号